Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucuronidase | 2 | 2020 | 11 | 1.350 |
Why?
|
| Skin | 6 | 2016 | 451 | 0.970 |
Why?
|
| Endothelial Cells | 4 | 2020 | 384 | 0.930 |
Why?
|
| Neovascularization, Physiologic | 2 | 2016 | 164 | 0.880 |
Why?
|
| Autoimmune Diseases | 2 | 2020 | 186 | 0.800 |
Why?
|
| Rheumatic Diseases | 1 | 2020 | 35 | 0.760 |
Why?
|
| Microvessels | 2 | 2016 | 43 | 0.650 |
Why?
|
| Foreskin | 1 | 2016 | 1 | 0.580 |
Why?
|
| Cell Movement | 2 | 2016 | 630 | 0.540 |
Why?
|
| Cell-Derived Microparticles | 1 | 2014 | 5 | 0.510 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 1293 | 0.500 |
Why?
|
| Connective Tissue Growth Factor | 4 | 2011 | 76 | 0.480 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 155 | 0.450 |
Why?
|
| Thrombosis | 1 | 2014 | 218 | 0.450 |
Why?
|
| Neovascularization, Pathologic | 2 | 2011 | 183 | 0.430 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1173 | 0.410 |
Why?
|
| Collagen | 5 | 2012 | 636 | 0.400 |
Why?
|
| Immediate-Early Proteins | 3 | 2008 | 63 | 0.380 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2008 | 146 | 0.370 |
Why?
|
| Lysophospholipids | 1 | 2011 | 209 | 0.350 |
Why?
|
| Sphingosine | 1 | 2011 | 315 | 0.330 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 756 | 0.310 |
Why?
|
| Dermis | 1 | 2004 | 29 | 0.240 |
Why?
|
| Viral Proteins | 1 | 2004 | 149 | 0.220 |
Why?
|
| Scleroderma, Systemic | 3 | 2020 | 446 | 0.210 |
Why?
|
| Fibroblasts | 7 | 2016 | 902 | 0.210 |
Why?
|
| Neutrophils | 1 | 2020 | 204 | 0.180 |
Why?
|
| Lupus Nephritis | 1 | 2020 | 193 | 0.170 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 3 | 2008 | 106 | 0.160 |
Why?
|
| RNA Interference | 2 | 2016 | 266 | 0.150 |
Why?
|
| Animals | 7 | 2020 | 20877 | 0.140 |
Why?
|
| Transfection | 2 | 2016 | 782 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 320 | 0.130 |
Why?
|
| Aging | 1 | 2020 | 911 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 498 | 0.120 |
Why?
|
| Humans | 11 | 2020 | 68525 | 0.110 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 27 | 0.110 |
Why?
|
| Estrogen Receptor beta | 1 | 2012 | 19 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 3 | 2004 | 384 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2673 | 0.110 |
Why?
|
| Decorin | 2 | 2012 | 8 | 0.110 |
Why?
|
| Lumican | 2 | 2012 | 8 | 0.110 |
Why?
|
| Keratan Sulfate | 2 | 2012 | 12 | 0.100 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2012 | 36 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 65 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2016 | 2688 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2013 | 447 | 0.100 |
Why?
|
| Proteoglycans | 2 | 2008 | 103 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 232 | 0.090 |
Why?
|
| Infant, Newborn | 1 | 2016 | 2453 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 322 | 0.090 |
Why?
|
| Age Factors | 1 | 2014 | 1860 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1663 | 0.090 |
Why?
|
| Time Factors | 2 | 2016 | 4655 | 0.090 |
Why?
|
| Fibrillar Collagens | 1 | 2008 | 49 | 0.080 |
Why?
|
| Extracellular Matrix | 3 | 2012 | 493 | 0.080 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 13 | 0.080 |
Why?
|
| Pepsin A | 1 | 2007 | 8 | 0.080 |
Why?
|
| Castration | 1 | 2007 | 13 | 0.080 |
Why?
|
| Fibromodulin | 1 | 2007 | 3 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2007 | 49 | 0.080 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 52 | 0.070 |
Why?
|
| Cell Culture Techniques | 2 | 2008 | 189 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2008 | 110 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 206 | 0.070 |
Why?
|
| Mice | 5 | 2013 | 8472 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 144 | 0.070 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2006 | 65 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2013 | 1692 | 0.070 |
Why?
|
| Male | 5 | 2020 | 37281 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2003 | 237 | 0.070 |
Why?
|
| Risk Factors | 1 | 2014 | 5719 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2004 | 59 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 1265 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2004 | 69 | 0.060 |
Why?
|
| Mutation | 1 | 2008 | 1213 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 700 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 411 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 614 | 0.050 |
Why?
|
| Sphingolipids | 1 | 2003 | 337 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 155 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 617 | 0.040 |
Why?
|
| Female | 4 | 2020 | 38015 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 945 | 0.030 |
Why?
|
| Collagen Type I | 2 | 2008 | 175 | 0.030 |
Why?
|
| Adenoviridae | 2 | 2006 | 295 | 0.030 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 7 | 0.030 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 25 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2013 | 21 | 0.030 |
Why?
|
| Fibrosis | 2 | 2006 | 371 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 58 | 0.030 |
Why?
|
| Matrix Metalloproteinase 15 | 1 | 2012 | 5 | 0.030 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2012 | 22 | 0.030 |
Why?
|
| Pneumonia | 1 | 2013 | 110 | 0.030 |
Why?
|
| Hypoxia | 1 | 2013 | 169 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 189 | 0.030 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1548 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2008 | 57 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 89 | 0.020 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1329 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2083 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 849 | 0.020 |
Why?
|
| Cell Division | 1 | 2008 | 541 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 21119 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 21375 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 2790 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1174 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 5300 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 1752 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 434 | 0.020 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2003 | 17 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 22 | 0.010 |
Why?
|
| Smad3 Protein | 1 | 2003 | 33 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 88 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 105 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 1849 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2006 | 753 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 258 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 756 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 562 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2003 | 200 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 1047 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 626 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1199 | 0.010 |
Why?
|
| Ceramides | 1 | 2003 | 578 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 1660 | 0.010 |
Why?
|
| Aged | 1 | 2003 | 14842 | 0.000 |
Why?
|